Top Markets
Coin of the day
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Ранг среди акций #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Цена акции
$9.60
Последняя синхронизация: 2025-05-21
Рыночная капитализация
$1.08B
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля OptiNose, Inc. (OPTN)

Категория

EPS для OptiNose, Inc. (OPTN)
EPS по состоянию на March 2025 TTM: $-2.67
Согласно последним финансовым отчетам и цене акций OptiNose, Inc., текущий EPS компании (TTM) составляет $-2.67. В конце 2023 EPS компании составлял $-0.32, меньше, чем показателю 2022 года, равному $-13.05.
История EPS компании OptiNose, Inc. с 2015 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $-2.67 25.94%
2024 $-2.12 562.50%
2023 $-0.32 -97.55%
2022 $-13.05 806.25%
2021 $-1.44 -29.41%
2020 $-2.04 -21.54%
2019 $-2.60 -2.99%
2018 $-2.68 83.56%
2017 $-1.46 -505.56%
2016 $0.36 -108.39%
2015 $-4.29 0.00%
EPS для аналогичных компаний или конкурентов